C4 Therapeutics (CCCC) Non-cash Items (2019 - 2022)

C4 Therapeutics has reported Non-cash Items for 4 years, with the latest figure at $1.7 million in Q1 2022.

• For the quarter ending Q1 2022, Non-cash Items rose 214.0% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2022 stood at $1.7 million (up 214.0% YoY), and the FY2021 full-year result was $1.4 million, up 199.03% from the prior year.
• Non-cash Items for Q1 2022 stood at $1.7 million, up from $1.4 million in the prior quarter.
• The five-year high for Non-cash Items was $102.6 million in Q4 2020, with the low at $365732.0 in Q3 2020.
• Average Non-cash Items over 4 years is $14.2 million, with a median of $1.2 million recorded in 2021.
• Year-over-year, Non-cash Items jumped 2037.78% in 2020 and sank 98.67% in 2021.
• Tracing CCCC's Non-cash Items over 4 years: stood at $4.8 million in 2019, then jumped by 2037.78% to $102.6 million in 2020, then slumped by 98.67% to $1.4 million in 2021, then increased by 22.43% to $1.7 million in 2022.
• The last three Non-cash Items figures came in at $1.7 million (Q1 2022), $1.4 million (Q4 2021), and $1.1 million (Q3 2021), per Business Quant data.

Peer Comparison